Hematologic consequences of exposure to ionizing radiation.

Area of Science:

• Hematology
• Radiation Biology
• Toxicology

Background:

• Ionizing radiation (IR) has been known since the early 1900s to impair hematopoiesis.
• IR directly damages hematopoietic stem cells and bone marrow stromal elements.
• IR exposure causes dose-dependent declines in circulating hematopoietic cells via reduced production, redistribution, and apoptosis.

Purpose of the Study:

• To present a practical strategy for estimating radiation dose and triaging victims based on clinical symptomatology.
• To review the molecular and cellular pathways mediating hematologic responses to IR.
• To discuss the long-term hematologic complications of IR exposure.

Main Methods:

• Utilizing lymphocyte depletion kinetics for crude radiation dose estimation.
• Clinical assessment and symptomatology for victim triage.
• Review of molecular and cellular mechanisms of IR-induced hematologic damage.

Main Results:

• Lymphocyte depletion kinetics provide a method for rapid dose estimation in mass exposure scenarios.
• IR disrupts DNA, gene expression, transcription, and intracellular signaling pathways.
• Leukemia is a significant hematologic complication, particularly in childhood exposures.
• Multiple myeloma may be associated with chronic, low-dose IR exposure in older individuals.

Conclusions:

• A practical strategy combining clinical assessment and lymphocyte kinetics aids in managing IR-exposed individuals.
• Understanding molecular pathways is crucial for comprehending IR's hematologic effects.
• Long-term risks include leukemia and potentially multiple myeloma, with varying risk factors based on age and exposure type.